Human BTLA (31-134) Protein

• Catalog Number: orb257229
• Category: Proteins
• Description: B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.
• Reactivity: Human
• Tag: C-Fc
• Form/Appearance: Powder
• Purity: 92%
• Conjugation: Unconjugated
• MW: 38.7 kDa
• Target: BTLA
• Protein Sequence: NP_001078826.1
• Source: Human BTLA, Fc Tag (orb257229) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Thr 134 (Accession # NP_001078826.1).
• Expression System: HEK293
• Expression Region: Lys 31 - Thr 134
• Endotoxins: 1.0 EU per μg
• NCBI: NP_001078826.1
• Storage: -20℃
• Buffer/Preservatives: Tris with Glycine, Arginine and NaCl, pH7.5
• Alternative names: BTLA,CD272
• Note: For research use only
• Application notes: This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 38.7 kDa. The protein migrates as 45-50 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
• Expiration Date: 6 months from date of receipt.

SDS-PAGE analysis of Human BTLA protein